LLY compared with QURE: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

QUREuniQure N.V.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

QUREuniQure N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,440.80▲+1.61%

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

QUREuniQure N.V.

21.66▼−5.93%

Regular sessionNov 5 '26

Mkt cap$1.6BRevenue$5MQ3 FY26Revenue$16MFY25

Compare

Regular sessionNov 5 '26

LLYELI Lilly & Co

QUREuniQure N.V.

1,440.80▲+1.61%

Price

21.66▼−5.93%

$1.3T

Mkt cap

$1.6B

Q3 FY26$24.4B

Revenue

$5MQ3 FY26

FY25$65.2B

Revenue

$16MFY25

LLY1,440.80▲+1.61%vsQURE21.66▼−5.93%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

QURE: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only QURE 9

FDMT4D Molecular Therapeuticssupplier

RGNXRegenxbiosupplier

—Apic Biounlistedsupplier

—Cold Spring Harbor Laboratory

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

5 more · QURE chain ›

Price

rebased to 0%

LLY, solidQURE, dashed